TXNDC5 and atherosclerosis: These results together demonstrate the effectiveness of this newly devised targeted nanomedicine approach to achieve endothelium-specific Txndc5 deletion and, moreover, establish the feasibility to spatially manipulate mechanosensitive genes in endothelium treating atherosclerosis in vivo.